Dr. Neff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6230 University Parkway
Sarasota, FL 34240Phone+1 941-500-3200- Is this information wrong?
Summary
- Dr. Guy Neff is a researcher in Sarasota, FL. He received his medical degree from Northeast Ohio Medical University and has been in practice 25 years. He is experienced in hepatology.
Education & Training
Louisiana State UniversityFellowship, Gastroenterology, 1995 - 1997
Canton Medical Education Foundation/NEOMEDResidency, Internal Medicine, 1992 - 1995- Aultman Hospital/NEOMEDInternship, Transitional Year, 1992 - 1992
Northeast Ohio Medical UniversityClass of 1992
Certifications & Licensure
FL State Medical License 1997 - 2026
OH State Medical License 1993 - 2012
LA State Medical License 1995 - 2001
IA State Medical License 1996 - 2000
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA) Start of enrollment: 2006 Sep 01
Publications & Presentations
PubMed
- 26 citationsA phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis.Christopher L Bowlus, Michael R Galambos, Richard J Aspinall, Gideon M Hirschfield, David E J Jones, Yvonne Dörffel, Stuart C Gordon, Stephen A Harrison, Andreas E Kre...> ;Journal of Hepatology. 2022 Aug 1
- 34 citationsA phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes.Stephen A. Harrison, Nadege Gunn, Guy W. Neff, Anita Kohli, Liping Liu, Abbey Flyer, Lawrence Goldkind, Adrian M. Di Bisceglie> ;Nature Communications. 2021 Sep 17
- 31 citationsEmricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosisCatherine Frenette, Zeid Kayali, Edward Mena, Parvez S. Mantry, Kathryn J. Lucas, Guy W. Neff, Miguel Á. Rodríguez, Paul J. Thuluvath, Ethan M. Weinberg, Bal R. Bhanda...> ;Journal of Hepatology. 2021 Feb 1
- Join now to see all
Press Mentions
Echosens Observes October 2018 Liver Cancer Awareness Month: Know Your Risk for Nonalcoholic Fatty Liver Disease – A Looming National EpidemicOctober 17th, 2018- Research Points to National Epidemic of Undiagnosed Fatty Liver Disease: Florida Research Institute and Echosens Announce Results at the American College of GastroenterologyOctober 9th, 2018
NASH – A Silent Killer: 150 World Experts Sign a Global Call to Action to Promote Awareness of Deadly Liver DiseaseJune 5th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
